In fact, patients with chronic inflammatory diseases have been demonstrated to have decreased red cell survival, disorders of erythropoiesis, EPO levels low for the degree of anemia, and progressive EPO resistance of erythroid progenitors. This evidence concerns the gene EPO and anemia (phenotype).